Company Medgenics, Inc. Nyse

Equities

US58436Q2030

Biotechnology & Medical Research

Business Summary

Share class

Shareholders

Company contact information

Sector

Sector Other Biotechnology & Medical Research

Inactive Instrument

End-of-day quote Nyse Other stock markets
- ^USD	-

2020	Aevi Genomic Medicine, LLC(NasdaqGM:GNMX) dropped from S&P TMI Index	CI
2020	Aevi Genomic Medicine, Inc. Announces Resignation of Directors	CI

Aevi Genomic Medicine, Inc., formerly Medgenics, Inc., is focused on genomic medicine. The Company is engaged in unlocking the potential of genomic medicine to translate genetic discoveries into therapies. The Company is engaged in developing therapies for children and adults with pediatric onset life altering diseases. The Company's product candidates include AEVI-001 and AEVI-002. The Company's research and development efforts leverage an internal genomics platform and a collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). .

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	77,713,782	59,472,216 ( 76.53 %)	0	76.53 %

Name	Equities	%	Valuation
Verity Asset Management, Inc. -	0	-	- $

Aevi Genomic Medicine, Inc.

435 Devon Park Drive Suite 715

19087, Wayne

+610-254-4201

http://www.medgenics.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
IQVIA HOLDINGS INC.	-0.09%	42.12B
LONZA GROUP AG	+49.62%	42.05B
CELLTRION, INC.	-4.96%	29.18B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.02B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	18.9B
BIO-TECHNE CORPORATION	+8.61%	13.21B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.17B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-6.26%	11.42B

Other Biotechnology & Medical Research